Skip to main content

Advertisement

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Gastrointestinal Cancer Excellence Forum

Gastrointestinal Cancer
Excellence Forum
Leaders in the field sharing authoritative insights and institutional best practices.

Anup Kasi, MD, University of Kansas Cancer Center
Videos
04/20/2023
Anup Kasi, MD, discusses the debate on neoadjuvant vs adjuvant immunotherapy for patients with locally advanced HER2-positive upper gastrointestinal tract cancers, held at the 2023 Great Debates and Updates in GI Malignancies in Chicago.
Anup Kasi, MD, discusses the debate on neoadjuvant vs adjuvant immunotherapy for patients with locally advanced HER2-positive upper gastrointestinal tract cancers, held at the 2023 Great Debates and Updates in GI Malignancies in Chicago.
Anup Kasi, MD, discusses the...
04/20/2023
Oncology
Arvind Dasari, MD, MD Anderson Cancer Center
Videos
04/13/2023
Arvind Dasari, MD, discusses the important points clinicians should consider when treating patients with neuroendocrine tumors.
Arvind Dasari, MD, discusses the important points clinicians should consider when treating patients with neuroendocrine tumors.
Arvind Dasari, MD, discusses the...
04/13/2023
Oncology
Arvind Dasari, MD, MD Anderson Cancer Center
Videos
04/13/2023
Arvind Dasari, MD, reviews the new and upcoming treatment options for patients with neuroendocrine tumors at the 2023 Great Debates and Updates in GI Malignancies in Chicago.
Arvind Dasari, MD, reviews the new and upcoming treatment options for patients with neuroendocrine tumors at the 2023 Great Debates and Updates in GI Malignancies in Chicago.
Arvind Dasari, MD, reviews the...
04/13/2023
Oncology
Sonia Kupfer, MD, University of Chicago
Videos
04/01/2023
At the 2023 Great Debates & Updates in Gastrointestinal Malignancies in Chicago, regional co-chair Sonia Kupfer, MD, discussed the significant part that genetics play when treating patients with gastrointestinal cancers.
At the 2023 Great Debates & Updates in Gastrointestinal Malignancies in Chicago, regional co-chair Sonia Kupfer, MD, discussed the significant part that genetics play when treating patients with gastrointestinal cancers.
At the 2023 Great Debates &...
04/01/2023
Oncology
Gary Deng, MD, Memorial Sloan Kettering Cancer Center
Videos
04/01/2023
At the 2023 Great Debates and Updates in Gastrointestinal Cancers meeting in Chicago, Gary Deng, MD, PhD, highlighted the pillars of cancer wellness and explained how to incorporate integrative medicine into the management of patients with...
At the 2023 Great Debates and Updates in Gastrointestinal Cancers meeting in Chicago, Gary Deng, MD, PhD, highlighted the pillars of cancer wellness and explained how to incorporate integrative medicine into the management of patients with...
At the 2023 Great Debates and...
04/01/2023
Oncology
Suneel Kamath, MD, Cleveland Clinic
Videos
03/31/2023
Suneel Kamath, MD, gives an overview of his talk on circulating tumor DNA from the 2023 Great Debates and Updates in Gastrointestinal Malignancies meeting in Chicago, IL.
Suneel Kamath, MD, gives an overview of his talk on circulating tumor DNA from the 2023 Great Debates and Updates in Gastrointestinal Malignancies meeting in Chicago, IL.
Suneel Kamath, MD, gives an...
03/31/2023
Oncology
Nataliya Uboha, MD, PhD, University of Wisconsin
Videos
03/30/2023
At the 2023 Great Debates and Updates in Gastrointestinal Malignancies in Chicago, Nataliya Uboha, MD, PhD, gave an overview of her presentation on biomarkers and targeting treatment for gastroesophageal cancers.
At the 2023 Great Debates and Updates in Gastrointestinal Malignancies in Chicago, Nataliya Uboha, MD, PhD, gave an overview of her presentation on biomarkers and targeting treatment for gastroesophageal cancers.
At the 2023 Great Debates and...
03/30/2023
Oncology
Sebastian Stintzing, MD, Charité — Berlin University of Medicine
Videos
02/08/2023
Sebastian Stintzing, MD, shares results from the phase 3 FIRE-4 trial showing the administration of an initial cycle of chemotherapy had no effect on the efficacy of first-line FOLFIRI plus cetuximab therapy for patients with RAS wild-type...
Sebastian Stintzing, MD, shares results from the phase 3 FIRE-4 trial showing the administration of an initial cycle of chemotherapy had no effect on the efficacy of first-line FOLFIRI plus cetuximab therapy for patients with RAS wild-type...
Sebastian Stintzing, MD, shares...
02/08/2023
Oncology
John Strickler, MD, Duke University
Videos
02/02/2023
John Strickler, MD, shares insights on the FDA’s accelerated approval of tucatinib in combination with trastuzumab for patients with RAS wild-type, HER2-positive colorectal cancer.
John Strickler, MD, shares insights on the FDA’s accelerated approval of tucatinib in combination with trastuzumab for patients with RAS wild-type, HER2-positive colorectal cancer.
John Strickler, MD, shares...
02/02/2023
Oncology
Michael Hall, MD, Fox Chase Cancer Center
Podcasts
12/20/2022
Michael Hall, MD, reviews his presentation from the 2022 Great Debates & Updates in Gastrointestinal Malignancies virtual meeting, on genetic testing for gastrointestinal cancers.
Michael Hall, MD, reviews his presentation from the 2022 Great Debates & Updates in Gastrointestinal Malignancies virtual meeting, on genetic testing for gastrointestinal cancers.
Michael Hall, MD, reviews his...
12/20/2022
Oncology

Advertisement

Advertisement

Advertisement

Advertisement